Sincalide

drugbox
IUPAC_name = 3- [2- [2- [2- [2- [2- [(2-amino-3-carboxy-propanoyl)
amino] -3-(4-sulfooxyphenyl)propanoyl] amino] -4-
methylsulfanyl-butanoyl] amino] acetyl] amino] -3-
(1"H"-indol-3-yl)propanoyl] amino] -4-methylsulfanyl-
butanoyl] amino] -3- [(1-carbamoyl-2-phenyl-ethyl)
carbamoyl] propanoic acid

---

CAS_number = 25126-32-3
ATC_prefix = V04
ATC_suffix = CC03
PubChem = 32800
DrugBank =
C=49|H=62|N=10|O=16|S=3
molecular_weight = 1143.27 g/mol
synonyms = 1-De(5-oxo-L-proline)-2-de-L-glutamine-
5-L-methioninecaerulein
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US = B
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US = Rx-only
legal_status = Available on a named-patient basis (UK)
routes_of_administration = Intravenous

Sincalide (INN) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin.

External links

* [http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202739.html Sincalide] on NIH.gov